Erratum: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597)

George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung Ju Ahn; Chao Hua Chiu; Jessica J. Lin; Koichi Goto; Jeeyun Lee; Lyudmila Bazhenova; Thomas John; Marwan Fakih; Sant P. Chawla; Rafal Dziadziuszko; Takashi Seto; Sebastian Heinzmann; Bethany Pitcher; David Chen; Timothy R. Wilson; Christian Rolfo

doi:10.1158/1078-0432.CCR-22-1108

Erratum: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597)

George D. Demetri
, Filippo De Braud
, Alexander Drilon
, Salvatore Siena
, Manish R. Patel
, Byoung Chul Cho
, Stephen V. Liu
, Myung Ju Ahn
, Chao Hua Chiu
, Jessica J. Lin
, Koichi Goto
, Jeeyun Lee
, Lyudmila Bazhenova
, Thomas John
, Marwan Fakih
, Sant P. Chawla
, Rafal Dziadziuszko
, Takashi Seto
, Sebastian Heinzmann
, Bethany Pitcher

David Chen, Timothy R. Wilson, Christian Rolfo

Department of Internal Medicine

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Abstract

In the earlier version of this article as it was published online on February 10, 2022 (1) and in the printed article, the disclosures of Salvatore Siena and Jeeyun Lee were missing. The HTML and PDF versions of this article were corrected in the online release of the April 1, 2022 issue (2). The publisher regrets the error.

Original language	English
Pages (from-to)	2196
Number of pages	1
Journal	Clinical Cancer Research
Volume	28
Issue number	10
DOIs	https://doi.org/10.1158/1078-0432.CCR-22-1108
State	Published - 15 May 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1158/1078-0432.CCR-22-1108

Fingerprint

Dive into the research topics of 'Erratum: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597)'. Together they form a unique fingerprint.

Cite this

Demetri, G. D., De Braud, F., Drilon, A., Siena, S., Patel, M. R., Cho, B. C., Liu, S. V., Ahn, M. J., Chiu, C. H., Lin, J. J., Goto, K., Lee, J., Bazhenova, L., John, T., Fakih, M., Chawla, S. P., Dziadziuszko, R., Seto, T., Heinzmann, S., ... Rolfo, C. (2022). Erratum: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597). Clinical Cancer Research, 28(10), 2196. https://doi.org/10.1158/1078-0432.CCR-22-1108

@article{311c01eda102411faf42d025128a93c1,

title = "Erratum: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597)",

abstract = "In the earlier version of this article as it was published online on February 10, 2022 (1) and in the printed article, the disclosures of Salvatore Siena and Jeeyun Lee were missing. The HTML and PDF versions of this article were corrected in the online release of the April 1, 2022 issue (2). The publisher regrets the error.",

author = "Demetri, \{George D.\} and \{De Braud\}, Filippo and Alexander Drilon and Salvatore Siena and Patel, \{Manish R.\} and Cho, \{Byoung Chul\} and Liu, \{Stephen V.\} and Ahn, \{Myung Ju\} and Chiu, \{Chao Hua\} and Lin, \{Jessica J.\} and Koichi Goto and Jeeyun Lee and Lyudmila Bazhenova and Thomas John and Marwan Fakih and Chawla, \{Sant P.\} and Rafal Dziadziuszko and Takashi Seto and Sebastian Heinzmann and Bethany Pitcher and David Chen and Wilson, \{Timothy R.\} and Christian Rolfo",

note = "Publisher Copyright: {\textcopyright}2022 American Association for Cancer Research",

year = "2022",

month = may,

day = "15",

doi = "10.1158/1078-0432.CCR-22-1108",

language = "English",

volume = "28",

pages = "2196",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

Demetri, GD, De Braud, F, Drilon, A, Siena, S, Patel, MR, Cho, BC, Liu, SV, Ahn, MJ, Chiu, CH, Lin, JJ, Goto, K, Lee, J, Bazhenova, L, John, T, Fakih, M, Chawla, SP, Dziadziuszko, R, Seto, T, Heinzmann, S, Pitcher, B, Chen, D, Wilson, TR & Rolfo, C 2022, 'Erratum: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597)', Clinical Cancer Research, vol. 28, no. 10, pp. 2196. https://doi.org/10.1158/1078-0432.CCR-22-1108

Erratum: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597). / Demetri, George D.; De Braud, Filippo; Drilon, Alexander et al.
In: Clinical Cancer Research, Vol. 28, No. 10, 15.05.2022, p. 2196.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597)

AU - Demetri, George D.

AU - De Braud, Filippo

AU - Drilon, Alexander

AU - Siena, Salvatore

AU - Patel, Manish R.

AU - Cho, Byoung Chul

AU - Liu, Stephen V.

AU - Ahn, Myung Ju

AU - Chiu, Chao Hua

AU - Lin, Jessica J.

AU - Goto, Koichi

AU - Lee, Jeeyun

AU - Bazhenova, Lyudmila

AU - John, Thomas

AU - Fakih, Marwan

AU - Chawla, Sant P.

AU - Dziadziuszko, Rafal

AU - Seto, Takashi

AU - Heinzmann, Sebastian

AU - Pitcher, Bethany

AU - Chen, David

AU - Wilson, Timothy R.

AU - Rolfo, Christian

PY - 2022/5/15

Y1 - 2022/5/15

N2 - In the earlier version of this article as it was published online on February 10, 2022 (1) and in the printed article, the disclosures of Salvatore Siena and Jeeyun Lee were missing. The HTML and PDF versions of this article were corrected in the online release of the April 1, 2022 issue (2). The publisher regrets the error.

AB - In the earlier version of this article as it was published online on February 10, 2022 (1) and in the printed article, the disclosures of Salvatore Siena and Jeeyun Lee were missing. The HTML and PDF versions of this article were corrected in the online release of the April 1, 2022 issue (2). The publisher regrets the error.

UR - https://www.scopus.com/pages/publications/85130033704

U2 - 10.1158/1078-0432.CCR-22-1108

DO - 10.1158/1078-0432.CCR-22-1108

M3 - Comment/debate

C2 - 35553647

AN - SCOPUS:85130033704

SN - 1078-0432

VL - 28

SP - 2196

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 10

ER -

Erratum: Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion–Positive Solid Tumors (Clin Cancer Res (2022) 28 (1302–1312) DOI: 10.1158/1078-0432.ccr-21-3597)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this